No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last iteration of the shot did in 2023.

CVS expects elevated medical costs to continue to pressure its performance this year, “and as a result we are not providing a ...

The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...

While liberals have held their tongues as Kamala Harris tacked to the center, they're preparing for a major battle over the ...

Bristol Myers Squibb reported third-quarter earnings and revenue that blew past expectations on strong sales from its blood ...

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...

Employers’ biggest concern is higher drug costs, according to the National Alliance of Healthcare Purchaser Coalitions report.

Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company ...

Ohioans must recognize the threat that vertically-integrated insurance conglomerates pose to our health and pocketbooks.

The pharmaceutical giant also hiked its full-year outlook and now expects to book adjusted earnings per share of $2.75 to ...

One exception that enjoys bipartisan support, however, is the effort to rehab the drug supply chain. It’s currently dominated ...